CHEMED CORP (CHE) › Cash & EquivalentsCHEMED CORP (CHE) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2007: $4.99M2008: $3.63M2009: $112.42M2010: $49.92M2011: $38.08M2012: $69.53M2013: $84.42M2014: $14.13M2015: $14.73M2016: $15.31M2017: $11.12M2018: $4.83M2019: $6.16M2020: $162.68M2021: $32.90M2022: $74.13M2023: $263.96M2024: $178.35M2025: $74.52M$74.52M2007Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$74.52M-58.2%2024$178.35M-32.4%2023$263.96M+256.1%2022$74.13M+125.3%2021$32.90M-79.8%2020$162.68M+2541.7%2019$6.16M+27.5%2018$4.83M-56.6%2017$11.12M-27.4%2016$15.31M+4.0%2015$14.73M+4.2%2014$14.13M-83.3%2013$84.42M+21.4%2012$69.53M+82.6%2011$38.08M-23.7%2010$49.92M-55.6%2009$112.42M+2998.6%2008$3.63M-27.3%2007$4.99M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share